|
注册号: Registration number: |
ChiCTR2200066134 |
|
最近更新日期: Date of Last Refreshed on: |
2023-05-08 19:41:35 |
|
注册时间: Date of Registration: |
2022-11-25 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
血清维生素D水平与血管性认知障碍患者神经心理学特征及铁代谢指标的相关性研究 |
|
Public title: |
Correlation analysis between serum vitamin D level and neuropsychological characteristics and iron metabolism markers in patients with vascular cognitive impairment |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
血清维生素D水平与血管性认知障碍患者神经心理学特征及铁代谢指标的相关性研究 |
|
Scientific title: |
Correlation analysis between serum vitamin D level and neuropsychological characteristics and iron metabolism markers in patients with vascular cognitive impairment |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
谷正盛 |
研究负责人: |
毕晓莹 |
|
Applicant: |
Zhengsheng Gu |
Study leader: |
Xiaoying Bi |
|
申请注册联系人电话: Applicant telephone: |
+86 187 9620 1026 |
研究负责人电话:
Study leader's |
+86 137 9527 4796 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
gzs1996@smmu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
bixiaoying2013@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市杨浦区翔殷路168号长海医院 |
研究负责人通讯地址: |
上海市杨浦区翔殷路168号长海医院 |
|
Applicant address: |
168 Changhai Road, Yangpu District, Shanghai, China |
Study leader's address: |
168 Changhai Road, Yangpu District, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
海军军医大学第一附属医院(上海长海医院) |
||
|
Applicant's institution: |
Changhai Hospital of Shanghai |
||
|
研究负责人所在单位: |
海军军医大学第一附属医院(上海长海医院) |
||
|
Affiliation of the Leader: |
Changhai Hospital of Shanghai |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
CHEC2022-203 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海长海医院伦理委员会 |
||
|
Name of the ethic committee: |
Shanghai Changhai Hospital Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-10-28 00:00:00 | ||
|
伦理委员会联系人: |
张伦琴 |
||
|
Contact Name of the ethic committee: |
Lunqin Zhang |
||
|
伦理委员会联系地址: |
上海市杨浦区翔殷路168号长海医院 |
||
|
Contact Address of the ethic committee: |
168 Changhai Road, Yangpu District, Shanghai, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 139 1835 5518 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
海军军医大学第一附属医院(上海长海医院) |
||||||||||||||||||||||
|
Primary sponsor: |
Changhai Hospital of Shanghai |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市杨浦区翔殷路168号长海医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
168 Changhai Road, Yangpu District, Shanghai, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
海军军医大学第一附属医院“234 学科攀峰计划”资助项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
the funding project from Changhai Hospital of Shanghai |
||||||||||||||||||||||
|
研究疾病: |
血管性认知障碍 |
||||||||||||||||||||||
|
Target disease: |
vascular cognitive impairment |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
病例对照研究 |
||||||||||||||||||||||
|
Study design: |
Case-Control study |
||||||||||||||||||||||
|
研究目的: |
1、探究血清维生素D水平包括25羟维生素D、1,25二羟维生素D水平与血管性认知障碍患者神经心理学特征和血清铁代谢指标的相关性; 2. 借助定量磁敏感图技术,分析血清维生素D水平与VCI患者脑铁沉积、脑白质高信号和白质微结构变化的相关性。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. To explore the relationship between serum vitamin D level and neuropsychological characteristics and iron metabolism markers in patients with vascular cognitive impairment; 2. Using quantitative susceptibility mapping to perform the correlation analysis between serum vitamin D level and iron deposition in the CNS, white matter hyperintensities and microstructural changes in patients with vascular cognitive impairment. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.由脑血管病以外的神经系统疾病所导致的认知障碍,如AD、帕金森病、多发性硬化、颅内感染、颅内肿瘤、颅脑创伤、药物滥用及酗酒等; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients whose cognitive impairment are caused by other diseases except cerebrovascular diseases; 2. Patients with severe aphasia, dysarthria, visual and auditory impairment; 3. Patients with mental diseases which may affect their cooperation in the test; 4. Patients with systemic iron metabolism abnormalities or diseases that can lead to brain iron deposition; 5. Patients with contraindications for cranial MRI; 6. Vitamin D3 intake greater than 800IU/d or supplemental calcium intake greater than 1200mg/d. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-11-24 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-11-25 00:00:00 至 To 2025-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
观察性研究,不需要使用随机方法入组患者 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This is an observational study and there is no need for the randomization procedure. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
以发表论文的形式公布试验数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Publish the data in the form of an article. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |